Page results
-
Once you have completed treatment for cancer at UCLH you will enter a period of follow-up care. Follow-up is an important way of monitoring your health.
-
The oral and maxillofacial surgery department focuses on the delivery of care to patients with dento-alveolar needs.
-
The rhinology unit covers all aspects of nose and sinus disease including allergy, infection, inflammatory/mucosal conditions, breathing disorders and tumours.
-
The Adult Cerebral Palsy service offers comprehensive multidisciplinary assessment and care to adults with cerebral palsy and neuro-disability.
-
The Neurometabolic unit provides a unique range of investigations and clinical laboratory advice encompassing mitochondrial, neurotransmitter, pterin and amino acid disorders.
-
Information for patients having chemotherapy for ovarian, tubal or primary peritoneal cancer, or who have been newly diagnosed with pancreatic cancer or cholangiocarcinoma.
-
Enhanced supportive care is specialist care that aims to manage and minimise pain and other symptoms caused by cancer or cancer treatment.
-
Anaemia is a condition in which the body has fewer red blood cells, or have less haemoglobin in the red blood cells, than normal. Patients who may have anaemia can be referred to general haematology by GPs and hospital doctors.
-
The bone marrow transplant and haematopoietic stem cell transplant service at UCLH is the largest in Europe and provides a full range of transplant services.
-
A blood transfusion involves taking blood from a donor and giving it to someone else. UCLH is one of the largest and most complex blood establishments in the UK.
File results
-
Council of Governors meeting papers - 31 October
-
Consultant - to -consultant referral form
-
UCLH Provider to Provider Tariff 2019-20
-
What young people would like everyone to know about Type 1 Diabetes
-
Reverse mentoring
-
FOI/2020/0572 - Inflamatory bowel disease staff contact details
-
FOI2017294 Contactors and subcontractors working on the Phase 4 and proton therapy beam
-
FOI/2020/0589 - Senior staff contacts for CEO, Director of Innovation and Chief Pharmacist
-
FOI/2020/0630 - CEO, Operations Director and Health and Safety Director contact details
-
FOI2017333 Midwifery contacts for accessing return to practice placements